Potassium acetate, a new class 3 drug of HISCO, will enter the site for inspection
-
Last Update: 2014-12-12
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
According to the website of the State Food and Drug Administration (CFDA), the three kinds of new drug potassium acetate of Hisilicon will enter the site for inspection, which means that the drug only needs to pass the inspection of production environment and production process, and is expected to be approved in the first half of next year Potassium acetate can supplement the potassium ion needed by human body, and is used to maintain the balance of body fluid composition and electrolyte According to the information from the State Food and drug administration, at present, there are no enterprises in China to produce the drug At the same time, Hengrui pharmaceutical, Kelun pharmaceutical, Shanxi Guorun pharmaceutical and Shenyang Pharmaceutical union technology apply for the drug Hisilicon is mainly engaged in the production and sales of chemical pharmaceutical preparations and APIs According to the information from the State Food and drug administration, Hisilicon has nearly 20 new drugs in application for production, involving parenteral and enteral nutrition drugs, dermatology, rheumatoid, endocrine and other fields.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
